Your browser doesn't support javascript.
loading
Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei, Yu; Hoogerland, Joanne A; Bloks, Vincent W; Bos, Trijnie; Bleeker, Aycha; Wolters, Henk; Wolters, Justina C; Hijmans, Brenda S; van Dijk, Theo H; Thomas, Rachel; van Weeghel, Michel; Mithieux, Gilles; Houtkooper, Riekelt H; de Bruin, Alain; Rajas, Fabienne; Kuipers, Folkert; Oosterveer, Maaike H.
Afiliação
  • Lei Y; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Hoogerland JA; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Bloks VW; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Bos T; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Bleeker A; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Wolters H; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Wolters JC; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Hijmans BS; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • van Dijk TH; Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Thomas R; Dutch Molecular Pathology Center, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • van Weeghel M; Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Mithieux G; Core Facility of Metabolomics, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
  • Houtkooper RH; National Institute of Health and Medical Research, U1213, Lyon, France.
  • de Bruin A; University of Lyon, Lyon, France.
  • Rajas F; University of Lyon 1, Villeurbanne, France.
  • Kuipers F; Laboratory Genetic Metabolic Diseases, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.
  • Oosterveer MH; Department of Pediatrics, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Hepatology ; 72(5): 1638-1653, 2020 11.
Article em En | MEDLINE | ID: mdl-32083759
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Depósito de Glicogênio Tipo I / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Hepatopatia Gordurosa não Alcoólica / Fígado Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Depósito de Glicogênio Tipo I / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos / Hepatopatia Gordurosa não Alcoólica / Fígado Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Hepatology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Holanda País de publicação: Estados Unidos